Upload
zanna
View
35
Download
1
Embed Size (px)
DESCRIPTION
PSORIASIS 2010 Congress of the Psoriasis International Network PARIS, July 1-4, 2010 Palais des Congr è s. Current Psoriasis Situation in China. Zheng Min , M.D. Dermatology Department Second Hospital Zhejiang University, School of Medicine 浙江大学医学院附属第二医院郑敏. - PowerPoint PPT Presentation
Citation preview
Current Psoriasis Current Psoriasis Situation in ChinaSituation in China
Zheng MinZheng Min ,, M.D.M.D.Dermatology DepartmentDermatology DepartmentSecond HospitalSecond HospitalZhejiang University, School of MedicineZhejiang University, School of Medicine浙江大学医学院附属第二医院郑敏浙江大学医学院附属第二医院郑敏
PSORIASIS 2010Congress of the Psoriasis International Network
PARIS, July 1-4, 2010Palais des Congrès
Practical organisation of Chinese Psoriasis Network
National projects opportunitis to develop
international collaborations on specific topics
other issues
Chairman Prof. Zhu Xuejun, Chinese Dermatologist Association
Six National Psoriasis Center Institute of Dermatology, Chinese Academy of
Medical Sciences and Peking Union Medical College.Nanjing;
First Hospital Beijing Univerity.Beijing; Second Hospital Zhejiang University.Hangzhou; Huashan Hospital, Fudan University.Shanghai; Xijing Hospital, Fourth Military Medical
University; Xi’an ; Peking Union Medical College Hospital.Beijing.
Chinese Psoriasis Network
Geographic Coverage of 46 hospitals in China
未覆盖区域山西贵州四川西藏香港台湾
Practical organisation of Chinese Psoriasis Network
National projects opportunitis to develop
international collaborations on specific topics
other issues
World Psoriasis Day event Targeted Patients
Epidermological Investigation National Treatment Guideline
National projects
Press conference focus on national psoriasis prevention and treatment on 29. Oct.
Prof. Zhu Xuejun, chairman of China Dermatologist Association, in Press conference in International day of Psoriasis
Beijing
Shanghai
Hangzhou
46 hospitals in different cities of China
4879 cases of psoriasis
(2009.Nov.23-Dec. 12) ●●
●
●
● ●●
●
●
●●●
●●
●●
●
●
●
●●
●●
●●
●●
● ●●
●
●
●
●
●
● ●●
●
●●●
●
●●
New Data 2009New Data 2009
46 hospitals in China 4879 cases of psoriasis vulgaris Male, 61.14%; Female, 38.86% , Male : Female=1.57 : 1 Mean age 40.49±22.11
Family history of psoriasis: 22.84% (1057/4628)
62.53 % in first degree relatives 62.53 % in first degree relatives 27.72 % in second degree relatives27.72 % in second degree relatives 9.76 % in third degree relativesin third degree relatives
Genetic epidemiologyGenetic epidemiology
Peak age of first onsetPeak age of first onset male: 20~29 years male: 20~29 years female: 10~19 yearsfemale: 10~19 years
Zhang XJ et al: Analyses of Genetic Epidemiology of Psoriasis VulgarisChinese Journal of Dermatology 2000;33(6):383-385.
Psoriasis vulgaris may be a Psoriasis vulgaris may be a multigenic inheritable disease multigenic inheritable disease and the genetic factors play an and the genetic factors play an important role in the important role in the pathogenesis of psoriasis.pathogenesis of psoriasis.
Zhang XJ et al: Analyses of Genetic Epidemiology of Psoriasis VulgarisChinese Journal of Dermatology 2000;33(6):383-385.
Causative factorCausative factor
Psychological factorPsychological factor
Infection, wound
Alcohol, diet, smoking, drug
Endocrine and metabolic diseaseEndocrine and metabolic disease
Relapse and aggratateRelapse and aggratate
Season, especially winter (83.36%) Psychological factor Pharyngolaryngitis or tonsillitisPharyngolaryngitis or tonsillitis Alcohol and food Medicine and smoking
Releave SeasonReleave Season
Summer ( 90.56% ) Spring Paracmasia: 14.06±37.93 m
Clinical Type of psoriasis Clinical Type of psoriasis in China in China Psoriasis vulgaris: 4489 ( 92.01% ) Guttae 26.09% Plaque 57.01% Mix 16.91% Psoriasis pustulosa: 169 ( 3.46% ) Psoriasis erythroderma: 79 ( 1.62% ) Psoriasis arthropathica: 142 例( 2.91% )。
19.67%: 932/4737 have accompanied disease
High blood pressure: 576 ( 12.16% ) Diabetes: 237 ( 5.00% ) Coronary heart disease:149 ( 3.15% ) Hyperlipemia: 340 ( 7.18% ) Rheumatoid arthritis: 61 ( 1.29% ), Tumor: 40 ( 0.84% )。
ComorbiditiesComorbidities in psoriatic patientsin psoriatic patients
ManagementManagement
Systemic therapy;Systemic therapy;Topical therapy;Topical therapy;Patient education.Patient education.
79.55% (3809/4788)79.55% (3809/4788) Traditional Chinese Medicine Traditional Chinese Medicine
89.47% 89.47% Acitretin Acitretin 22.06% 22.06% MTX 5.64%MTX 5.64% Immunosupressants 14.02%Immunosupressants 14.02% Steroids 13.30%Steroids 13.30% Others 27.59%Others 27.59%
Systemic treatmentSystemic treatment
Systemic treatmentSystemic treatment Methotrexate 7.5mg/weekMethotrexate 7.5mg/week widespread plaque, senile personwidespread plaque, senile person Acitretin 0.5mg/kg.dAcitretin 0.5mg/kg.d erythroderma and pustular psoriasiserythroderma and pustular psoriasis Cyclosporin A 5mg/kg.d psoriasis arthritisCyclosporin A 5mg/kg.d psoriasis arthritis Corticosteroids.Corticosteroids. BiologicsBiologics Alternative therapy TCMAlternative therapy TCM
Topical therapyTopical therapy
90.34% (4283/4741)90.34% (4283/4741) Topical steroids: 85.59%Topical steroids: 85.59% Vitamin D3 analogue: 31.64%Vitamin D3 analogue: 31.64% Topical retinoids: 27.01%Topical retinoids: 27.01% Salicylic acid: 18.98%Salicylic acid: 18.98% Coal tar: 14.57%Coal tar: 14.57% Anthralin: 3.34%Anthralin: 3.34% Topical TCM: 23.67%Topical TCM: 23.67% Others: 25.40%Others: 25.40%
Physical therapyPhysical therapy
26.54%: 124426.54%: 1244//46884688 NB-UVB NB-UVB >> 50%50% UVBUVB PUVAPUVA
Insurance and treatment costs Insurance and treatment costs
71.2% patients have a social medical 71.2% patients have a social medical insurance (non-commercial), and insurance (non-commercial), and 7.43% patients attend other 7.43% patients attend other commercial medical insurancecommercial medical insurance
In the past 6 months, about 29.84% In the past 6 months, about 29.84% went to see a dermatologist 6 times. went to see a dermatologist 6 times. The mean fees is $101±2000, and The mean fees is $101±2000, and about $52±100 were paid by patients about $52±100 were paid by patients themselvesthemselves 。。
Insurance and treatment costsInsurance and treatment costs
In the past 2 years, 7.07% patients were In the past 2 years, 7.07% patients were accepted in the hospital and 0.21% were in accepted in the hospital and 0.21% were in the hospital more than 6 times. the hospital more than 6 times.
The duration in the hospital is 27.26±46.27dThe duration in the hospital is 27.26±46.27d,, mean spent is $1100±1200mean spent is $1100±1200 ,, and the and the patients themselves have to pay $600±1000patients themselves have to pay $600±1000
QOL
18.73% patients were affected severely, 29.45% moderately , and 37.56% slightly. Only 14.27% were unaffected.
13.31% patients’ family expenditure were affected greatly, 25.96% moderately, 38.90% slightly and 21.82% unaffected.
Update our National Treatment Guideline according to the new data from evidence based medicine:
National Disease Registration; National Epi Invetigation; International co-operation.
More to do
Practical organisation of Chinese Psoriasis Network
National projects Opportunitis to develop
international collaborations on specific topics and other issues
Comparison study on the background between Eastern and Western in genetics and clinical pattern background
Some mechanism study on traditional Chinese Medicine on psoriasis
…….
THANK YOU !THANK YOU !
Beijing
ShanghaiHangzhou
Zhejiang Univ. School of Zhejiang Univ. School of Med.Med.